HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology

Clinical Investigation
doi 10.4155/cli.14.62
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

ErbB-2/Her2/neu Overexpression and Estrogen-Dependency in Breast Carcinogenesis

2005English

An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

HER2/neu (ERBB2) Expression and Gene Amplification Correlates With Better Survival in Esophageal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

Identification of Tumorsphere- And Tumor-Initiating Cells in HER2/Neu-Induced Mammary Tumors

Cancer Research
Cancer ResearchOncology
2007English

Type I Protein Arginine Methyltransferases Overexpression Promotes Transformation and Potentiates Her2/Neu–Driven Tumorigenesis

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy